GLP-1/GIP Tirzepatide

Tirzepatide 101: An Overview

• What is compounded tirzepatide?

  Tirzepatide is a dual GLP-1/GIP receptor agonist. A compounded tirzepatide prescription may be prepared by a state-licensed pharmacy for an individual patient when a licensed prescriber determines it is appropriate. Compounded drugs are not FDA-approved and are not the same as FDA-approved brand medications.

  If prescribed, your clinician will determine the appropriate strength and dosing schedule. The dispensing pharmacy and formulation details may vary based on your state, prescriber direction, and availability.

• How does tirzepatide work?

  Tirzepatide acts on GLP-1 and GIP pathways involved in appetite and metabolic regulation. For eligible patients, it may be prescribed as part of a personalized, clinician-guided weight-management plan. Treatment suitability and results vary by individual.

• Where is compounded tirzepatide produced?

  FancyMeds works with state-licensed compounding pharmacies to prepare compounded tirzepatide prescriptions in accordance with applicable state and federal requirements. Pharmacy partners are expected to follow applicable quality and regulatory standards.

• Is tirzepatide safe? What are the side effects?


  As with any prescription medication, tirzepatide may carry risks and side effects. Patients should use tirzepatide only under the supervision of a licensed healthcare provider and discuss questions about risks, side effects, and treatment considerations before and during care.

  Reported side effects may include nausea, vomiting, diarrhea, and constipation, among others. Side effects and overall treatment experience vary by individual. Patients should promptly report side effects or concerns to their healthcare provider.

• What is the recommended dosage for tirzepatide?


  Dosing typically begins at a lower dose and may be adjusted over time based on your clinician’s judgment and your individual response. If prescribed, your healthcare provider will determine your dosage and schedule based on your clinical needs.

• How do you use tirzepatide?

  If prescribed, compounded tirzepatide may be supplied in sterile vials for subcutaneous self-injection. Patients are typically instructed by their clinician or dispensing pharmacy on how to prepare and administer each dose. In many cases, injections are administered into the fatty tissue of the abdomen, thigh, or upper arm, as directed. Tirzepatide is commonly prescribed as a once-weekly injection, but your exact dosing schedule and administration instructions should always follow the guidance provided by your healthcare provider and dispensing pharmacy.

• What are the risks of self-administering compounded tirzepatide?

  It is important to follow prescribed dosing, preparation, and administration instructions to help reduce the risk of complications. Potential risks may include:

  • Overdosing, which may lead to symptoms such as nausea, vomiting, or other adverse effects.

  • Underdosing, which may reduce treatment effectiveness.

  • Improper preparation, handling, or sanitation, which may increase the risk of contamination or infection.

  If prescribed, patients may receive educational resources on proper preparation and administration. Patients should always follow the instructions provided by their clinician and dispensing pharmacy.

• Will my insurance cover compounded tirzepatide?

  Insurance coverage for compounded tirzepatide varies by plan, and many plans may not cover compounded medications. Some patients may be able to use FSA or HSA funds for eligible expenses, depending on their plan terms and benefits administrator.

  If your FSA or HSA card is declined, you may complete your purchase using another payment method and contact [email protected] to request available documentation that may assist with reimbursement, subject to your plan’s requirements.